NEU 5.50% $16.15 neuren pharmaceuticals limited

2HCY16? "Trofinetide provides an opportunity potentially to be...

  1. 229 Posts.
    lightbulb Created with Sketch. 42
    2HCY16? "Trofinetide provides an opportunity potentially to be the first approved therapy for one or more of these important indications." You're having a laugh BP!

    Day 1:
    Trading Halt Regarding Results
    Day 3:
    Positive Results from Intrepid
    Day 4:
    Trading Halt Regarding Offer from Novartis
    Day 5:
    Trading Halt Regarding Counter Offer from Vertex
    AIMO

    Can't be long now, looking forward to the kickoff!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$16.15
Change
-0.940(5.50%)
Mkt cap ! $2.064B
Open High Low Value Volume
$15.04 $16.33 $14.65 $25.91M 1.638M

Buyers (Bids)

No. Vol. Price($)
1 125 $16.15
 

Sellers (Offers)

Price($) Vol. No.
$16.20 1500 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.